Wilian Augusto Cortopassi Coelho

Title: Wilian Augusto Cortopassi Coelho: Innovator in Malaria Treatment

Introduction

Wilian Augusto Cortopassi Coelho is a notable inventor based in San Francisco, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of malaria, a disease that continues to pose a major public health challenge worldwide.

Latest Patents

Wilian holds a patent for a compound derived from quinoline, which is aimed at treating conditions caused by blood parasites. His invention addresses the urgent need for new drugs to combat malaria, especially in light of the growing resistance to existing treatments. The patent details the use of CQ analogues that exhibit high activity against both CQ-sensitive and CQ-resistant blood parasites, demonstrating effectiveness in laboratory mice. This innovation is crucial as it provides new pharmaceutical compositions and methods for treating malaria, which affected 219 million people and resulted in 435,000 deaths in 2017.

Career Highlights

Wilian is associated with the Fundação Oswaldo Cruz, an esteemed research institution known for its contributions to public health and biomedical research. His work focuses on developing new therapeutic strategies to combat malaria, reflecting his commitment to addressing global health issues.

Collaborations

Wilian has collaborated with notable colleagues such as Antoniana Ursine Krettli and Anna Caroline Campos Aguiar. Their combined expertise enhances the research efforts aimed at finding effective treatments for malaria.

Conclusion

Wilian Augusto Cortopassi Coelho's innovative work in developing new treatments for malaria highlights the importance of ongoing research in combating infectious diseases. His contributions are vital in the fight against malaria, showcasing the potential for new therapies to save lives.